We can provide a wide range of APIS mentioned below for Indian as well as international market. Our documentation is complete & can provide the ODMF upon signing the CDA. Samples are also available upon request.
Powder for Suspension (PFS)
- TASTE MASKED READY TO FILL/PACK DRUG PRODUCTS
- Azithromycin 7.5% /8% /15% Granules/Powder(Taste Masked PFS)
- Ciprofloxacin 20% Pellets (Taste Masked Pellets for Suspension)
- Ciprofloxacin 20% /30% /40% Granules/Powder(Taste Masked PFS)
- Sildenafil 2 % Taste Masked Granular Powder
- Clarithromycin Taste Masking
| SR. NO. | API NAME | CATEGORY | SPECIFICATION | CAS NO. | DOCUMENT STATUS |
|---|---|---|---|---|---|
| 1 | Tigecycline | Tetracycline Antibiotic | USP / EP | DMF | |
| 2 | Moxifloxacin | Antibacterial Antibiotic | USP / EP | DMF | |
| 3 | Colistimethate Sodium | USP | DMF | ||
| 4 | Moxifloxacin Hydrochloride | IP/USP | 186826-86-8 | Tech Pack | |
| 5 | Tamsulosin | Alpha Blockers | IH (In House) | DMF | |
| 6 | Bupropion | Antidepressants | USP / EP | DMF | |
| 7 | Silodosin | Antiadrenergic Agents | 160970-54-7 | Under Development | |
| 8 | Dabigatran Etexilate Mesylate | Anticoagulant | IH (In House) | 872728-81-9 | ODMF |
| 9 | Rivaroxaban | 366789-02-8 | Under Development | ||
| 10 | Racecadotril | Antidiarrheal | IH (In House) | DMF | |
| 11 | Racecadotril | IP/BP/ EP | 81110-73-8 | ODMF | |
| 12 | Valproic Acid | Antiepileptic | USP | DMF | |
| 13 | Sodium Valproate | USP | DMF | ||
| 14 | Magnesium Valproate | USP | DMF | ||
| 15 | Levetiracetam | IP/USP/EP | 102767-28-2 | Tech Pack | |
| 16 | Fluconazole | Antifungal | USP / EP | DMF/CEP | |
| 17 | Cetirizine | Antihistaminic | USP / EP | DMF | |
| 18 | Levocetirizine | USP / EP | DMF | ||
| 19 | Diltiazem Hydrochloride | Antihypertensive | IP/BP/ EP | 33286-22-5 | ODMF |
| 20 | Nebivolol Hydrochloride | IP/USP/BP/EP | 152520-56-4 | Under Development | |
| 21 | Strontium Ranelate | Antiosteoporotic | IH (In House) | DMF | |
| 22 | Ropinirole Hydrochloride | Antiparkinsons | III / EP | 91374-20-8 | Under Development |
| 23 | Etravirine | Antiviral | 269055-15-4 | Under Development | |
| 24 | Aripiprazole | Atypical Antipsychotic | IH (In House) | DMF | |
| 25 | Paliperidone palmitate | 199739-10-1 | Under Development | ||
| 26 | Diltiazem HCl | Calcium Channel Blockers | USP / EP | DMF | |
| 27 | Deferasirox | Oral Iron Chulator | IH (In House) | DMF | |
| 28 | Ticagrelor | Platelet Aggregation Inhibitor | Under Development | ||
| 29 | Levetiracetam | Racetam Anticonvulsant | USP / EP | DMF | |
| 30 | Solifenacin | Urinary Antipasmodics | 242478-37-1 | Under Development | |
| 31 | Tamsulosin Hydrochloride | Urlogical | IH (In House)/USP | 106463-17-6 | ODMF |
| 32 | Benfotiamine | Vitamin B1 | USP | DMF |
For More Details
Enquire now© Copyrights 2021 KRV Pharma | Web Development by MagicWorks